Next Article in Journal
L-Arginine Supplementation and Metabolism in Asthma
Previous Article in Journal
Cardiorenal Effects of Kappa Opioid Peptides During Ontogeny
Previous Article in Special Issue
Antifungal Properties of Chenopodium ambrosioides Essential Oil Against Candida Species
Open AccessReview

Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata

Medical University Vienna, Christian Doppler Laboratory for Infection Biology, Max F. Perutz Laboratories, Campus Vienna Biocenter, Dr. Bohr-Gasse 9/2, A-1030 Vienna, Austria
Author to whom correspondence should be addressed.
Pharmaceuticals 2011, 4(1), 169-186;
Received: 14 December 2010 / Revised: 22 December 2010 / Accepted: 5 January 2011 / Published: 11 January 2011
(This article belongs to the Special Issue Anti-Infective Agents)
Candida glabrata is a major opportunistic human fungal pathogen causing superficial as well as systemic infections in immunocompromised individuals and several other patient cohorts. C. glabrata represents the second most prevalent cause of candidemia and a better understanding of its virulence and drug resistance mechanisms is thus of high medical relevance. In contrast to the diploid dimorphic pathogen C. albicans, whose ability to undergo filamentation is considered a major virulence trait, C. glabrata has a haploid genome and lacks the ability to switch to filamentous growth. A major impediment for the clinical therapy of C. glabrata infections is its high intrinsic resistance to several antifungal drugs, especially azoles. Further, the development of antifungal resistance, particularly during prolonged and prophylactic therapies is diminishing efficacies of therapeutic interventions. In addition, C. glabrata harbors a large repertoire of adhesins involved in the adherence to host epithelia. Interestingly, genome plasticity, phenotypic switching or the remarkable ability to persist and survive inside host immune cells further contribute to the pathogenicity of C. glabrata. In this comprehensive review, we want to emphasize and discuss the mechanisms underlying virulence and drug resistance of C. glabrata, and discuss its ability to escape from the host immune surveillance or persist inside host cells. View Full-Text
Keywords: Candida glabrata; fungal pathogenesis; virulence; drug resistance Candida glabrata; fungal pathogenesis; virulence; drug resistance
MDPI and ACS Style

Tscherner, M.; Schwarzmüller, T.; Kuchler, K. Pathogenesis and Antifungal Drug Resistance of the Human Fungal Pathogen Candida glabrata. Pharmaceuticals 2011, 4, 169-186.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop